Related Experiment Video
Updated: Jul 9, 2026

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Role of PAR2 in murine pulmonary pseudomonal infection
Theo J Moraes1, Raiza Martin, Jonathan D Plumb
1Academic Affairs, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA.
Abstract:
Proteinases can influence lung inflammation by various mechanisms, including via cleavage and activation of protease-activated receptors (PAR) such as PAR2. In addition, proteinases such as neutrophil and/or Pseudomonas-derived elastase can disarm PAR2 resulting in loss of PAR2 signaling. Currently, the role of PAR2 in host defense against bacterial infection is not known. Using a murine model of acute Pseudomonas aeruginosa pneumonia, we examined differences in the pulmonary inflammatory response between wild-type and PAR2(-/-) mice. Compared with wild-type mice, PAR2(-/-) mice displayed more severe lung inflammation and injury in response to P. aeruginosa infection as indicated by higher bronchoalveolar lavage fluid neutrophil numbers, protein concentration, and TNF-alpha levels. By contrast, IFN-gamma levels were markedly reduced in PAR2(-/-) compared with wild-type mice. Importantly, clearance of P. aeruginosa was diminished in PAR2(-/-) mice. In vitro testing revealed that PAR2(-/-) neutrophils killed significantly less bacteria than wild-type murine neutrophils. Further, both neutrophils and macrophages from PAR2(-/-) mice displayed significantly reduced phagocytic efficiency compared with wild-type phagocytes. Stimulation of PAR2 on macrophages using a PAR2-activating peptide resulted in enhanced phagocytosis directly implicating PAR2 signaling in the phagocytic process. We conclude that genetic deletion of PAR2 is associated with decreased clearance of P. aeruginosa. Our data suggest that a deficiency in IFN-gamma production and impaired bacterial phagocytosis are two potential mechanisms responsible for this defect.
Insights
Protease-activated receptor 2 (PAR2) plays a crucial role in host defense against Pseudomonas aeruginosa lung infections. Lacking PAR2 impairs bacterial clearance and increases lung inflammation, suggesting PAR2 is vital for immune cell function.
Area of Science:
- Immunology
- Pulmonary Medicine
- Microbiology
Background:
- Proteinases modulate lung inflammation via protease-activated receptors (PARs), including PAR2.
- The function of PAR2 in host defense against bacterial pneumonia remains unclear.
- Bacterial proteases can inhibit PAR2 signaling, potentially impacting immune responses.
Purpose of the Study:
- To investigate the role of PAR2 in the host defense against acute Pseudomonas aeruginosa pneumonia.
- To compare the pulmonary inflammatory response in wild-type and PAR2-deficient (PAR2(-/-)) mice.
Main Methods:
- A murine model of acute Pseudomonas aeruginosa pneumonia was utilized.
- Pulmonary inflammation and injury were assessed by measuring bronchoalveolar lavage fluid (BALF) neutrophil counts, protein concentration, and cytokine levels (TNF-alpha, IFN-gamma).
- Bacterial clearance, neutrophil bacterial killing, and phagocytic efficiency of neutrophils and macrophages were evaluated in vitro.
Main Results:
- PAR2(-/-) mice exhibited exacerbated lung inflammation and injury compared to wild-type mice.
- Reduced levels of IFN-gamma and impaired clearance of P. aeruginosa were observed in PAR2(-/-) mice.
- Neutrophils and macrophages from PAR2(-/-) mice showed significantly reduced bacterial killing and phagocytic capacity, which could be restored by PAR2 stimulation.
Conclusions:
- Genetic deletion of PAR2 impairs host defense against P. aeruginosa lung infection.
- Deficiencies in IFN-gamma production and phagocytosis are key mechanisms underlying the reduced bacterial clearance in PAR2(-/-) mice.
- PAR2 signaling is critical for effective immune cell function in combating bacterial pneumonia.
Related Concept Videos
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
